Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled tri... by Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Rammohan Reddy Mogulla, Vijay Yerroju, Chirag Dhar, Siddalingaiah Ningaiah, Mallikarjuna Panchakshari, Chandrashekhar S. Gillurkar, Manish Narang, Shivnitwar Sachin Kisan, A. Venkateshwar Rao

Get full text